New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
07:56 EDTCBSTCubist price target raised to $90 from $80 at Leerink
Leerink raised its price target for Cubist Pharmaceuticals shares to $90 after its survey of Pharmacy Directors indicated less potential Sivextro price erosion once Zyvox becomes generic than it previously assumed. The firm keeps an Outperform rating on the stock.
News For CBST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
05:33 EDTCBSTCubist opens international headquarters in Zurich, will invest $400M in R&D
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use